<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05099588</url>
  </required_header>
  <id_info>
    <org_study_id>280/15-04-2020</org_study_id>
    <nct_id>NCT05099588</nct_id>
  </id_info>
  <brief_title>The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece</brief_title>
  <acronym>GR-ROP</acronym>
  <official_title>The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece: a Multicenter Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Athens General Children's Hospital &quot;Pan.&amp;Aglaia Kyriakou&quot;, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agia Sofia Children's Hospital, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Attikon General Hospital, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Iaso Neonatology Clinic, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>REA Maternity Hospital, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ippokratio General Hospital, Thessaloniki, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital of Patras, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital of Larisa, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital of Ioannina, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital of Heraklion, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Venizeleio General Hospital of Heraklion, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General University Hospital of Alexandroupoli, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective observational study of the incidence of treatment-requiring ROP (TR-ROP), at a&#xD;
      national level, in Greece.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this observational study is to prospectively collect data on ROP cases&#xD;
      necessitating treatment at a national level. Each and every ROP screening unit in Greece&#xD;
      (collaborating centers) report their new TR-ROP cases, their demographics and treatment&#xD;
      characteristics, monthly, for a 12-month period. A reminder email is sent to avoid&#xD;
      under-reporting due to neglect. Data are collected by the Responsible Party and will be&#xD;
      analyzed together with national registry data on all preterm births in the same 12-month&#xD;
      period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of treatment-requiring ROP (TR-ROP) in Greece</measure>
    <time_frame>During the study period (1 year, prospectively)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The mean gestational age and birth weight of infants treated for ROP in Greece</measure>
    <time_frame>During the study period (1 year, prospectively)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of participants treated with laser photocoagulation versus anti-VEGF injection</measure>
    <time_frame>During the study period (1 year, prospectively)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The failure and recurrence rate of applied treatments for ROP</measure>
    <time_frame>During the follow-up period (6 months from treatment, prospectively)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Retinopathy of Prematurity</condition>
  <arm_group>
    <arm_group_label>Infants treated for ROP</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Other: observational study</intervention_name>
    <description>Observational study</description>
    <arm_group_label>Infants treated for ROP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All preterm infants who underwent treatment for ROP in a public or private hospital in&#xD;
        Greece during the 12-month study period.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Preterm infants undergoing screening for ROP, who developed TR-ROP and were treated&#xD;
             for ROP in one or two eyes.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Weeks</minimum_age>
    <maximum_age>50 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Papageorgiou General Hospital</name>
      <address>
        <city>Thessalon√≠ki</city>
        <zip>56429</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Adams GG, Bunce C, Xing W, Butler L, Long V, Reddy A, Dahlmann-Noor AH. Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open. 2017 Mar 21;7(3):e013366. doi: 10.1136/bmjopen-2016-013366.</citation>
    <PMID>28325857</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 19, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>Asimina Mataftsi</investigator_full_name>
    <investigator_title>Associate Professor in Ophthalmology, Paediatric Ophthalmology and Strabismus</investigator_title>
  </responsible_party>
  <keyword>Retinopathy of prematurity</keyword>
  <keyword>ROP</keyword>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Retinopathy of Prematurity</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

